Avian Chlamydiosis (Psittacosis): Diagnosis, Treatment, and Zoonotic Control in Pet Birds

Introduction

Avian chlamydiosis, historically termed psittacosis or ornithosis, is a systemic bacterial infection of birds caused primarily by Chlamydia psittaci. This obligate intracellular pathogen affects a broad range of avian species, with psittacine birds (parrots, cockatiels, budgerigars) serving as particularly important reservoirs [1]. The disease carries significant zoonotic potential, as infected birds can transmit the bacterium to humans through aerosolized respiratory secretions and dried feces [2, 3]. In pet bird populations, subclinical carriage is common, complicating both diagnosis and control. This article provides an exhaustive review of diagnostic modalities, therapeutic protocols, and biosecurity strategies for managing C. psittaci in companion avian practice.

Etiology and Pathogenesis

Chlamydia psittaci belongs to the family Chlamydiaceae, order Chlamydiales. The bacterium exists in two main morphological forms: the infectious, metabolically inactive elementary body (EB) and the replicative, intracellular reticulate body (RB). Infection begins when EBs attach to and enter epithelial cells of the respiratory tract, conjunctiva, or gastrointestinal mucosa. Inside the host cell, EBs differentiate into RBs within a membrane-bound inclusion, where they undergo binary fission. After several replication cycles, RBs redifferentiate into EBs and are released by cell lysis, spreading to adjacent tissues and organs [1].

Multiple genotypes of C. psittaci have been identified, with genotypes A through F and E/B showing varying host tropism. Genotype A is most commonly associated with psittacine birds, while genotype B is frequently found in pigeons [4, 5]. Recent molecular surveys have also detected Chlamydia ibidis and Chlamydia gallinacea in poultry and wild birds, expanding the known diversity of avian chlamydial agents [6, 7]. Coinfections with other pathogens, such as circovirus or low pathogenic avian influenza virus, can exacerbate clinical disease [8, 9].

Clinical Signs in Pet Birds

The clinical presentation of avian chlamydiosis ranges from acute fulminant disease to chronic, subclinical infection. Common signs include:

• Respiratory: dyspnea, nasal discharge, conjunctivitis, sinusitis.
• Ocular: unilateral or bilateral conjunctival hyperemia, chemosis, ocular discharge.
• Gastrointestinal: diarrhea (often greenish or urate-stained), anorexia, weight loss.
• Systemic: lethargy, ruffled feathers, depression, polyuria/polydipsia.
• Hepatic: hepatomegaly, biliverdinuria (green urates).
• Neurologic: tremors, ataxia, torticollis (less common).

In breeding aviaries, decreased hatchability, increased embryonic mortality, and weak chicks are reported [10]. Subclinically infected birds may shed the organism intermittently, especially during periods of stress, transport, or concurrent illness.

Diagnosis

Accurate diagnosis of avian chlamydiosis requires a combination of molecular, serological, and sometimes culture-based methods. The choice of assay depends on the clinical context, sample type, and laboratory capability.

Molecular Detection (PCR)

Polymerase chain reaction (PCR) targeting conserved genes such as ompA (outer membrane protein A), 16S rRNA, or the incA gene is the gold standard for active infection detection. Real-time PCR offers high sensitivity and specificity, allowing quantification of bacterial load. Samples include choanal and cloacal swabs, conjunctival swabs, feces, and tissue specimens (liver, spleen, lung). PCR can detect both viable and nonviable organisms, so positive results must be interpreted alongside clinical signs and history.

Numerous studies have employed PCR for prevalence surveys and outbreak investigations. For example, molecular screening of psittacines in Brazil revealed coinfection with C. psittaci and circovirus [8]. In Argentina, PCR-based genotyping identified C. psittaci in urban pigeons and psittacine aviaries [5, 10]. A survey of wild birds at Qinghai Lake, China, used PCR to detect Chlamydia spp. with a prevalence of 8.7% [11]. Similarly, seagulls from anthropogenic environments in Argentina showed a 12.5% positivity rate [12]. These data underscore the utility of PCR for surveillance and outbreak response.

Serology

Serological tests detect antibodies against C. psittaci and are useful for identifying past exposure or chronic infection. Common methods include:

• Complement fixation test (CFT): Traditional but less sensitive; detects antibodies to genus-specific lipopolysaccharide (LPS).
• Enzyme-linked immunosorbent assay (ELISA): Commercial ELISA kits using recombinant antigens (e.g., ompA or LPS) offer improved sensitivity and throughput. For a discussion of ELISA principles in veterinary diagnostics, see the article on Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus.
• Indirect immunofluorescence assay (IFA): Detects antibodies to specific chlamydial antigens; useful for serotyping.

Serology cannot distinguish active from past infection, and seroconversion may be delayed in acute cases. Paired serology (acute and convalescent) is recommended for definitive diagnosis.

Culture and Histopathology

Cell culture (e.g., McCoy cells, Vero cells) remains a reference method but is technically demanding, time-consuming, and requires BSL-2 facilities. Histopathology with Gimenez or modified Ziehl-Neelsen staining can reveal intracytoplasmic inclusions in tissue sections, but sensitivity is low.

Comparison of Diagnostic Methods

Treatment

Antimicrobial therapy aims to eliminate the intracellular pathogen and reduce shedding. Doxycycline is the drug of choice for avian chlamydiosis due to its excellent tissue penetration and intracellular activity. Treatment regimens include:

• Oral doxycycline: 25-50 mg/kg once daily for 45 days (psittacines). Medicated feed or water formulations are available for flock treatment.
• Injectable doxycycline: 75-100 mg/kg intramuscularly every 5-7 days (long-acting formulation) for 4-6 injections.
• Azithromycin: 40 mg/kg orally once daily for 5 days, then twice weekly for 6 weeks (alternative for doxycycline-intolerant birds).

Treatment duration is critical; short courses (<30 days) often fail to eliminate the infection, leading to relapse. Antimicrobial susceptibility testing is rarely performed, but resistance to tetracyclines has been reported in some isolates. A study evaluating neem (Azadirachta indica) leaf extract as an adjunct therapy in broilers coinfected with C. psittaci and low pathogenic avian influenza H9N2 showed reduced clinical signs and viral shedding, suggesting potential for alternative or complementary treatments [9].

Supportive care includes fluid therapy, nutritional support, and management of secondary infections. Birds should be isolated during treatment and for at least two weeks after completion to monitor for recurrence.

Zoonotic Control and Biosecurity

Chlamydia psittaci is a zoonotic pathogen capable of causing psittacosis in humans, characterized by flu-like symptoms, atypical pneumonia, and, in severe cases, systemic involvement [2, 1]. Veterinarians, bird owners, and laboratory personnel are at elevated risk. Control measures must address both the avian patient and the environment.

Biosecurity Measures for Veterinary Clinics

• Triage: Any bird presenting with respiratory or ocular signs should be isolated immediately.
• Personal protective equipment (PPE): N95 respirators, gloves, and eye protection during examination and sample collection.
• Environmental decontamination: C. psittaci is susceptible to 1% sodium hypochlorite, 70% ethanol, and quaternary ammonium compounds. Surfaces should be cleaned after each patient.
• Waste management: Contaminated bedding, feces, and carcasses should be double-bagged and incinerated or autoclaved.

Biosecurity for Bird Owners

• Quarantine: New birds should be isolated for 30-45 days and tested (PCR and serology) before introduction to an existing flock.
• Hygiene: Regular cleaning of cages, food bowls, and waterers with disinfectants. Avoid aerosolizing dried feces.
• Health monitoring: Annual screening of breeding stock, especially in aviaries with a history of chlamydiosis.
• Reporting: Suspected cases should be reported to public health authorities, as psittacosis is a notifiable disease in many jurisdictions.

Diagnostic and Control Workflow

The following Mermaid diagram outlines a recommended decision tree for managing suspected avian chlamydiosis in a pet bird population.

flowchart TD
    A[Bird with clinical signs or exposure history], > B{Initial diagnostic testing}
    B, > C[PCR on choanal/cloacal swab]
    B, > D[Serology (ELISA or CFT)]
    C, > E[PCR positive?]
    E, >|Yes| F[Confirm active infection]
    E, >|No| G[Consider other causes or latent infection]
    D, > H[Serology positive?]
    H, >|Yes| I[Past exposure or chronic infection]
    H, >|No| J[No detectable antibodies]
    F, > K[Initiate doxycycline therapy]
    K, > L[Isolate bird, implement biosecurity]
    L, > M[Repeat PCR 2 weeks post-treatment]
    M, > N[PCR negative?]
    N, >|Yes| O[Clinical recovery; release from isolation]
    N, >|No| P[Extend treatment or switch antimicrobial]
    I, > Q[Monitor for reactivation; consider PCR]
    J, > R[If high suspicion, repeat PCR in 2 weeks]

Conclusion

Avian chlamydiosis remains a diagnostic and therapeutic challenge in pet bird medicine due to the intracellular nature of C. psittaci, the prevalence of subclinical carriers, and the zoonotic risk. Molecular methods, particularly real-time PCR, provide the most reliable means of detecting active infection, while serology aids in identifying exposed individuals. Doxycycline-based protocols, administered for a minimum of 45 days, are the cornerstone of treatment. Strict biosecurity measures, including quarantine, PPE, and environmental disinfection, are essential to prevent transmission to humans and other birds. Ongoing surveillance using molecular tools, as demonstrated in studies from multiple continents [11, 13, 12, 14, 4, 5, 10], is critical for understanding the epidemiology of this pathogen and informing control strategies.

References

[1] Wang J, Wang B, Xiao J, et al. Chlamydia psittaci: a zoonotic pathogen causing avian chlamydiosis and psittacosis. Virulence. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39541409/

[2] Tomić DH, Krkljuš M, Gottstein Ž, et al. Zoonotic potential of Chlamydia psittaci: a case report. Front Vet Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41640945/

[3] Lustosa R, Ospina-Pinto MC, Barros T, et al. Introduction of Chlamydia psittaci into a hospital area by feral pigeons. Acta Trop. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39603441/

[4] Gedye K, Kulkarni P, Soon XQ, et al. A single genotype of Chlamydia psittaci (ST27) found in multiple species of birds in a zoological collection in New Zealand. N Z Vet J. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40456272/

[5] Madariaga MJ, Caraballo DA, Teijeiro ML, et al. Molecular detection and genotyping of Chlamydia psittaci in birds in Buenos Aires City, Argentina. Animals (Basel). 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39595337/

[6] Mekonnen YT, Indio V, Lucchi A, et al. Detection of Chlamydia ibidis in the neck skin microbiome of broiler carcasses at the end of slaughter. Ital J Food Saf. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41784027/

[7] Ospina-Pinto MC, Alves BF, Soares HS, et al. Chlamydia gallinacea in Brazilian backyard chicken farms. Braz J Microbiol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38573540/

[8] Antonio ES, Fraga RE, Sacramento P, et al. Molecular assessment of Chlamydia psittaci and Circovirus in psittacines from a CETAS in Bahia, Brazil. Braz J Microbiol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40011424/

[9] Hegazy AME, Morsy AM, Salem HM, et al. The therapeutic efficacy of neem (Azadirachta indica) leaf extract against coinfection with Chlamydophila psittaci and low pathogenic avian influenza virus H9N2 in broiler chickens. Poult Sci. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39142030/

[10] Riccio MB, García JP, Chiapparrone ML, et al. Outbreak of Chlamydia psittaci infection in a commercial psittacine breeding aviary in Argentina. Animals (Basel). 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38998071/

[11] Wu X, Lei F, Niu Y, et al. Molecular prevalence of Chlamydia spp. in wild birds from Qinghai Lake, China. Ir Vet J. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41168871/

[12] Origlia JA, Lorenti E, Nusblat L, et al. Molecular detection and characterization of Chlamydiaceae from seagulls associated to anthropogenic environments in Argentina. Vet Res Commun. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40970983/

[13] Long JM, Zhong HT, Deng YY, et al. Prevalence and genetic characteristics of avian Chlamydia in birds in Guangxi, Southwestern China. Microorganisms. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41011550/

[14] Hashemian SMM, Madani SA, Peighambari SM. Molecular survey of chlamydial infections in three public bird collections in Tehran, Iran. Vet Med Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40815057/

[15] Caspe SG, Hill H. Chlamydiosis in animals. Animals (Basel). 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39518853/